These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20483353)

  • 1. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
    Liu T; Peng H; Zhang M; Deng Y; Wu Z
    Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
    Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
    Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
    Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.
    Liu T; Zhang M; Zhang H; Sun C; Deng Y
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1225-32. PubMed ID: 18309509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
    Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 inhibitor, cucurbitacin┬áI, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-╬║B signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms involved in regulation of proliferation and apoptosis by STAT3 antisense oligonucleotide and chemotherapy in laryngeal cancer cells].
    Wang JG; Li XM; Chen YH; Lu XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Mar; 42(3):222-6. PubMed ID: 17633284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Notch1 on cell cycle, apoptosis and migration of laryngeal squamous cell carninoma cell line Hep-2].
    Jiao J; Li S
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):104-9. PubMed ID: 22780927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
    Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
    Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.
    Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S
    Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling.
    Zhang M; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
    Pancreas; 2010 Aug; 39(6):923-9. PubMed ID: 20182390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
    J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells.
    Li X; Wang H; Lu X; Di B
    Oncol Rep; 2010 Feb; 23(2):345-53. PubMed ID: 20043094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells.
    Zhang M; Bian ZG; Zhang Y; Wang JH; Kan L; Wang X; Niu HY; He P
    Mol Med Rep; 2014 Dec; 10(6):2905-11. PubMed ID: 25242136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
    Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
    Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.
    El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F
    Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
    Shao F; Lv M; Zheng Y; Jiang J; Wang Y; Lv L; Wang J
    Biochimie; 2015 Dec; 119():183-91. PubMed ID: 26549486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.